MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: U.S. Federal
*Funding: HHS
*HHS: Contracts, Contractors & Awards
*BARDA: Contracts (IDIQ, GWACS, Etc.), Contractors & Awardees
*Contractors & Awardees: BARDA
Emergent BioSolutions Inc (NYSE: EBS)*
Finance & Acquisitions: Emergent Biosolutions
Parents
Emergent BioSolutions Inc (NYSE: EBS)*
Children
2007: Market Cap=$344m (2007)
2011: Emergent BioSolutions broadens CDC contract by $101M (2011)
2011: Emergent BioSolutions Snags $1.25 Billion Contract (2011)
2013: Emergent BioSolutions deal to buy Cangene accelerates product development plans (2013)
2013: Emergent BioSolutions Shells Out $222 Million For Cangene (2013)
2014: Emergent BioSolutions Announces $35 Million Option Exercised
2016: Anthrax Vaccine Maker Emergent Hopes To Profit From Biotech Spinoff
2016: Emergent BioSolutions Completes Spin-Off of Aptevo Therapeutics NYSE:EBS
2024: Emergent BioSolutions Inc. 2023 Q4 - Results - Earnings Call Presentation
2025: Emergent BioSolutions Inc. 2024 Q4 - Results - Earnings Call Presentation
ADAPT PHARMA INC.
Cangene
Revenue: 1.793 billion USD (2021)
Trubion Pharmaceuticals
Jumps
*Key People: Emergent Biosolutions
Organization & Developments: Emergent Biosolutions